Quarry Thera Company Profile, Contacts & Intelligence

Quarry Thera Overview

Quarry Thera - a Biotech with a differentiated pipeline and an unprecedented platform Founded by Mikael Dolsten, MD, PhD, former CSO & RD President of Pfizer, and Professor Craig M. Crews, Ph.D. of Yale University, Quarry Thera is advancing the next generation of proximity-induced therapeutics based on molecular glues. Jeanne Magram, PhD, has recently joined the Quarry Thera team as CSO, bringing deep experience in drug discovery from leadership roles at several top pharmaceutical companies and as founding CSO of biotechs delivering therapeutics in both immunology and oncology. Molecular glues have emerged as a powerful new modality in drug development and combine proprietary DNA-encoded libraries, structurally enabled drug design, and sophisticated medicinal chemistry to address challenges with currently available therapeutic options, including sub-optimal efficacy, narrow therapeutic windows, limited cellular permeability, and selectivity challenges associated with targeting undruggable proteins. More information coming soon.

Headquarters

Challenges with Currently Available Therapeutic Options

Industry

Biotechnology Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Quarry Thera Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Quarry Thera People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Quarry Thera Workforce Composition

Seniority breakdown across 4 visible profiles.

Compare Similar Companies to Quarry Thera

Explore companies in related markets and compare their industry and employee estimates.